RxDoctor Payments Data

Kristin Hung, MD

Obstetrics & Gynecology · Boston, MANPI 1285945022

Payments from drug & device makers

$2,604in general payments, 2019–2025

Across 15 payments — averaging $173.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$827
  • Medtronic$759
  • C. R. Bard, Inc. & Subsidiaries$310
  • Axonics, Inc.$267
  • Bard Access Systems, Inc.$256
  • Caldera Medical, Inc$185

What the payments were for

  • Consulting fees$1,16645%
  • Travel & lodging$351%
  • Food & beverage$1,40354%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,604 in reported general payments places this provider in the 85th percentile of 910 obstetrics & gynecology providers in Massachusetts.

See all obstetrics & gynecology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$204,160
Medicare patients
287
Services billed
3,066

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron183$151,289
MyrbetriqMirabegron42$16,665
Estradiol182$13,266
Methenamine Hippurate49$4,039
Mirabegron ErMirabegron13$3,368
YuvafemEstradiol20$2,299
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst42$391
Ibuprofen41$117
Oxycodone Hcl39$59

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →